People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Petros Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $41.7M | $308.0M | 2021 |
Fady Boctor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Fady Boctor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John D. Shulman | 1 | 3 |
| Joshua N. Silverman | 1 | 3 |
| Wayne R. Walker | 1 | 2 |
| BRUCE T. BERNSTEIN | 1 | 2 |
| Mitchell Arnold | 1 | 1 |
| Gregory T. Bradley | 1 | 1 |
| Andrew R. Gesek | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.